Sabeen Mekan is the Chief Medical Officer at Zymeworks Inc. , leveraging extensive experience in oncology from leadership roles at Gilead Sciences, Daiichi Sankyo, and Bristol-Myers Squibb. A graduate of Aga Khan University, she specializes in late-stage clinical development and has led global lung and GI cancer drug franchises.
Her career demonstrates a consistent focus on advancing oncology research and development across multiple high-profile pharmaceutical organizations.
She has a specialized background in Hematology/Oncology from her fellowship at Northwell Health.
Read the full overview →
Current Role
Senior Vice President
Location
New York City Metropolitan Area, United States
Personality Overview
How Sabeen shows up
Cautious & Analytical
Systematic
Price-Sensitive
They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. They prefer to do thorough analysis of any situation. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Priorities
Topics Sabeen cares about
Oncology Drug Development
Her entire career has been dedicated to oncology clinical research and development at leading pharmaceutical companies like Gilead Sciences and Bristol-Myers Squibb.
Building Clinical Teams
She is actively and publicly recruiting qualified individuals for her growing clinical and biostatistics teams at Zymeworks.
+4 more topicsLogin to view topics
Career
Work history
4-2025
Senior Vice President
Zymeworks Inc.
4-2021 - 4-2025
Executive Director, Global Development Lead Lung/GI Franchise
Gilead Sciences
4-2019 - 4-2021
Senior Medical Director Oncology R & D
Daiichi Sankyo, Inc.
7-2016 - 4-2019
Medical Director- Oncology Clinical Development
Bristol-Myers Squibb
1-2015 - 7-2016
Medical Director
PAREXEL International
In the press
Media appearances
Zymeworks Inc. Appoints Dr. Sabeen Mekan as Senior Vice President .... Featured in Nasdaq
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.